awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48063769-9640D085-D0D1-4A17-AC9C-90598CBC8265
Q48063769-9640D085-D0D1-4A17-AC9C-90598CBC8265
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48063769-9640D085-D0D1-4A17-AC9C-90598CBC8265
Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption.
P2860
Q48063769-9640D085-D0D1-4A17-AC9C-90598CBC8265
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48063769-9640D085-D0D1-4A17-AC9C-90598CBC8265
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bafa9cf09dd50822921effda52510146635d6006
P2860
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).